Home > Insider Trading > Filing (0000899243-22-030551)

Filing Details

Accession Number:: 0000899243-22-030551
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-09-06 21:30:15
Reporting Period:: 2022-09-01

Accepted Time:: 2022-09-06 21:30:15
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1799191	Oncology Institute Inc.	TOI	()	DE

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1705748	Havencrest Healthcare Partners, L.p.	2100 Mckinney Ave, Suite 1760 Dallas TX 75201	No	No	Yes	No
1892154	Toi Hc I, Llc	2100 Mckinney Ave, Suite 1760 Dallas TX 75201	No	No	Yes	No
1893722	Havencrest Healthcare Partners Gp, Llc	2100 Mckinney Ave, Suite 1760 Dallas TX 75201	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2022-09-01	31,500	$6.16	15,343,712	No	4	S	Indirect	See footnote
Common Stock	Disposition	2022-09-02	41,783	$6.03	15,301,929	No	4	S	Indirect	See footnote
Common Stock	Disposition	2022-09-06	84,200	$5.91	15,217,729	No	4	S	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.38, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.91 to $6.21, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.65 to $6.27, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein.